B Group, Inc.
- SEC CIK
- 0002043476
Holdings, Q2 2026
Positions as of Jun 30, 2026, filed Aug 14, 2026.SEC
- Positions
- 18
- −2 vs. Q1 2026
- Total value
- $176.19M
- +$41.3M (+30.6%) vs. Q1 2026
Compare with Q1 2026: new, added, reduced and sold out
Positions
Long positions only. Changes compare share counts with Q1 2026.
| Security | Class | Shares | Value | % of portfolio | Change in shares | Action | History |
|---|---|---|---|---|---|---|---|
| ADMAADMA BIOLOGICS INC | COM | 3,262,542 | $27.31M | 15.50% | +55,000+1.7% | Added | View |
| PALIPALISADE BIO INC | COM | 11,414,285 | $23.86M | 13.54% | 00.0% | Unchanged | View |
| NRXPNRX PHARMACEUTICALS INC | COM NEW | 4,091,767 | $16.74M | 9.50% | +1,091,767+36.4% | Added | View |
| FTHSENSEI BIOTHERAPEUTICS INC | COM NEW | 610,169 | $15.25M | 8.66% | +610,169 | New | View |
| TSHATAYSHA GENE THERAPIES INC | COM SHS | 1,800,556 | $12.26M | 6.96% | 00.0% | Unchanged | View |
| PRAXPRAXIS PRECISION MEDICINES I | COM NEW | 33,237 | $11.13M | 6.32% | 00.0% | Unchanged | View |
| CLLSCELLECTIS S A | SPON ADS | 3,281,501 | $9.84M | 5.59% | 00.0% | Unchanged | View |
| ZLABZAI LAB LTD | ADR | 450,646 | $8.56M | 4.86% | 00.0% | Unchanged | View |
| GPCRSTRUCTURE THERAPEUTICS INC | SPONSORED ADS | 140,000 | $7.51M | 4.26% | +12,500+9.8% | Added | View |
| ORKAORUKA THERAPEUTICS INC | COM | 75,000 | $7.14M | 4.05% | 00.0% | Unchanged | View |
| IOVAIOVANCE BIOTHERAPEUTICS INC | COM | 1,500,000 | $6.24M | 3.54% | 00.0% | Unchanged | View |
| SYRESPYRE THERAPEUTICS INC | COM NEW | 70,000 | $6.21M | 3.53% | −30,000−30.0% | Reduced | View |
| AURAAURA BIOSCIENCES INC | COM | 764,243 | $5.43M | 3.08% | +166,667+27.9% | Added | View |
| ASMBASSEMBLY BIOSCIENCES INC | COM NEW | 175,706 | $4.83M | 2.74% | 00.0% | Unchanged | View |
| DRUGBRIGHT MINDS BIOSCIENCES INC | COM NEW | 67,500 | $4.74M | 2.69% | 00.0% | Unchanged | View |
| RAREULTRAGENYX PHARMACEUTICAL IN | COM | 135,000 | $4.51M | 2.56% | 00.0% | Unchanged | View |
| SGHTSIGHT SCIENCES INC | COM | 970,000 | $3.66M | 2.08% | 00.0% | Unchanged | View |
| FHTXFOGHORN THERAPEUTICS INC | COM | 200,000 | $976K | 0.55% | +98,000+96.1% | Added | View |
Options (1)
Put and call positions reported in the same filing. The value is that of the underlying shares, as reported on Form 13F.
| Security | Class | Puts | Calls |
|---|---|---|---|
| INVESCO QQQ TR46090E953 | PUT | $36.82M | – |
Sold out since Q1 2026 (3)
Positions held at the end of Q1 2026 that are no longer in this filing.
| Security | Class | Shares, Q1 2026 | Value, Q1 2026 | % of portfolio, Q1 2026 |
|---|---|---|---|---|
| APOGEE THERAPEUTICS INC03770N101 | COM | 7,500 | $631.28K | 0.47% |
| SOLENO THERAPEUTICS INC834203309 | COM | 7,500 | $251.1K | 0.19% |
| REPLREPLIMUNE GROUP INC | COM | 26,000 | $198.9K | 0.15% |
13F filings by quarter
| Quarter | Filed | Positions | Total value | Changes | Filing |
|---|---|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | 18 | $176.19M | vs. Q1 2026 | SEC |
| Q1 2026 | May 15, 2026 | 20 | $134.89M | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 17, 2026 | 15 | $134.95M | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 14, 2025 | 17 | $104.58M | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 14, 2025 | 15 | $115.78M | vs. Q1 2025 | SEC |
| Q1 2025 | May 15, 2025 | 17 | $115.09M | vs. Q4 2024 | SEC |
| Q4 2024 | Feb 14, 2025 | 18 | $163.6M | – | SEC |